Bruker Corporation (NASDAQ:BRKR) Shows Near-Term Bullish Momentum Despite Overvalued Fundamentals

Short-term price action and momentum indicators point toward a tactical upside bias, while WMDST values the stock as over-valued, creating a divergence between market internals and fundamental metrics.

Recent News

On August 6, 2025 the company announced multi-year contracts for explosives and chemical trace detection deployments across airports and defense customers, collectively exceeding $27 million. On August 12, 2025 the Board approved a quarterly cash dividend of $0.05 per share payable October 3, 2025 to holders of record as of September 23, 2025. On September 2–3, 2025 Bruker commenced and priced a public offering of $600.0 million of mandatory convertible preferred stock (6.375%), with expected net proceeds intended to repay portions of the company’s term loans and revolving borrowings.

Technical Analysis

ADX sits at 27.13, indicating a strong trend environment that gives technical signals more weight for near-term price behavior; strength reads above an emerging threshold without implying direction by itself.

DI+ shows a peak-and-reverse pattern, a bearish directional shift, while DI- trends lower, which signals bullish pressure from decreasing downside dominance; this split suggests recent directional leadership lost momentum but downside conviction fell as well.

MACD equals 1.01 and climbs above its signal (0.62); the MACD trend qualifies as a bullish momentum cross and favors positive short-term momentum continuation into the coming weeks.

MRO registers 8.67 on an increasing trend. Because the MRO sits positive, price sits above WMDST’s target and faces potential mean reversion pressure toward valuation anchors despite current upside momentum.

RSI at 52.79 and rising places momentum in neutral-to-positive territory rather than overbought; the rising RSI aligns with MACD’s bullish cross and supports continued short-term upside pressure.

Price closed at $38.11 above the 12‑day EMA ($36.22), the 20‑day average ($36.12) and the 50‑day average ($33.53), while remaining below the 200‑day average ($41.41). Short‑term moving averages trending up and the super trend support at $33.94 create a tactical bias toward higher intramonth levels, while the longer-term trend still holds resistance above.

Volume presently lags short‑ and medium‑term averages (today’s volume ~1.62M versus a 10‑day average ~3.25M and 50‑day ~3.93M), which suggests lower conviction behind the current price push and increases the chance that any move may stall without heavier participation.

 


Fundamental Analysis

Profitability: EBIT equals $16,200,000 and EBIT margin registers 2.03%, well below the industry peer mean of 19.35% and median of 19.47%, reflecting compressed operating profitability relative to peers. Operating margin equals 3.30% and gross margin equals 44.88%, showing reasonable gross economics but thin conversion into operating profit.

Top line and earnings: Total revenue equals $797,400,000 with revenue growth year-over-year at −104.56% and quarterly revenue change at −97.26% (both expressed as percentages), while YoY earnings growth reads 27.91% and QoQ earnings growth reads 42.95%. Reported EPS equaled $0.32 versus an estimate of $0.42, producing an EPS surprise of −23.81%.

Cash flow and liquidity: Operating cash flow totaled −$127,500,000 and free cash flow equaled −$148,800,000, producing a free cash flow yield of −2.64%. Cash and short‑term investments stand at $92,000,000 while net debt equals $2,343,300,000, producing material net leverage alongside negative cash conversion into free cash flow.

Leverage and coverage: Total debt equals $2,435,300,000, debt-to-equity runs ~135.0%, and debt-to-EBITDA sits near 33.68x. Interest coverage registers ~1.03x, indicating constrained coverage and sensitivity to operating volatility.

Working capital and efficiency: The cash conversion cycle equals 266.13 days versus an industry peer mean of 129.59 days, indicating extended cash tied up in working capital. Asset turnover registers 0.13 versus an industry peer mean of 0.1177, which shows modest asset efficiency but not enough to offset working capital strain.

Valuation: Trailing P/E measures ~815.12x while forward P/E sits near 59.59x; price-to-book equals 3.13x. WMDST values the stock as over-valued, driven by elevated multiples, negative free cash flow, elevated leverage and weak cash generation despite pockets of revenue and gross-margin strength.

MOST-RECENT QUARTERLY REPORT
REPORT PERIOD ENDING: 2025-06-30
REPORT DATE: 2025-08-04
NEXT REPORT DATE: 2025-11-05
CASH FLOW  Begin Period Cash Flow 187.7 M
 Operating Cash Flow -127.50 M
 Capital Expenditures -21.30 M
 Change In Working Capital -160.30 M
 Dividends Paid -7.60 M
 Cash Flow Delta -91.50 M
 End Period Cash Flow 96.2 M
 
INCOME STATEMENT REVENUE
 Total Revenue 797.4 M
 Forward Revenue 2.7 B
COSTS
 Cost Of Revenue 439.5 M
 Depreciation 56.1 M
 Depreciation and Amortization 56.1 M
 Research and Development 100.2 M
 Total Operating Expenses 771.1 M
PROFITABILITY
 Gross Profit 357.9 M
 EBITDA 72.3 M
 EBIT 16.2 M
 Operating Income 26.3 M
 Interest Income 2.9 M
 Interest Expense 15.7 M
 Net Interest Income -12.80 M
 Income Before Tax 500.0 K
 Tax Provision -3.10 M
 Tax Rate 21.0 %
 Net Income 7.6 M
 Net Income From Continuing Operations 4.2 M
EARNINGS
 EPS Estimate 0.42
 EPS Actual 0.32
 EPS Difference -0.10
 EPS Surprise -23.81 %
 Forward EPS 0.68
 
BALANCE SHEET ASSETS
 Total Assets 6.3 B
 Intangible Assets 2.6 B
 Net Tangible Assets -814.80 M
 Total Current Assets 2.2 B
 Cash and Short-Term Investments 92.0 M
 Cash 92.0 M
 Net Receivables 522.6 M
 Inventory 1.2 B
 Long-Term Investments 799.8 M
LIABILITIES
 Accounts Payable 243.0 M
 Short-Term Debt 55.7 M
 Total Current Liabilities 1.3 B
 Net Debt 2.3 B
 Total Debt 2.4 B
 Total Liabilities 4.5 B
EQUITY
 Total Equity 1.8 B
 Retained Earnings 2.4 B
VALUATION & PER-SHARE METRICS EQUITY & PER-SHARE METRICS
 Book Value Per-Share 11.89
 Shares Outstanding 151.716 M
 Revenue Per-Share 5.26
VALUATION
 Market Capitalization 5.6 B
 Enterprise Value 8.0 B
 Enterprise Multiple 110.451
Enterprise Multiple QoQ 13.583 %
Enterprise Multiple YoY -7.547 %
Enterprise Multiple IPRWA high: 142.585
BRKR: 110.451
median: 72.241
mean: 70.827
low: -148.838
 EV/R 10.015
CAPITAL STRUCTURE
 Asset To Equity 3.514
 Asset To Liability 1.417
 Debt To Capital 0.574
 Debt To Assets 0.384
Debt To Assets QoQ 7.82 %
Debt To Assets YoY 8493.512 %
Debt To Assets IPRWA high: 0.847
BRKR: 0.384
median: 0.348
mean: 0.325
low: 0.051
 Debt To Equity 1.35
Debt To Equity QoQ 16.052 %
Debt To Equity YoY 9045.935 %
Debt To Equity IPRWA high: 1.368
BRKR: 1.35
median: 0.697
mean: 0.658
low: 0.067
PRICE-BASED VALUATION
 Price To Book (P/B) 3.128
Price To Book QoQ -14.993 %
Price To Book YoY -45.533 %
Price To Book IPRWA high: 8.583
mean: 4.059
median: 3.432
BRKR: 3.128
low: 0.246
 Price To Earnings (P/E) 815.119
Price To Earnings QoQ 768.202 %
Price To Earnings YoY 524.571 %
Price To Earnings IPRWA BRKR: 815.119
high: 111.763
mean: 80.532
median: 79.394
low: -75.925
 PE/G Ratio -14.944
 Price To Sales (P/S) 7.076
Price To Sales QoQ -15.188 %
Price To Sales YoY -44.855 %
Price To Sales IPRWA high: 37.916
mean: 17.394
median: 15.972
BRKR: 7.076
low: 0.528
FORWARD MULTIPLES
Forward P/E 59.588
Forward PE/G -1.092
Forward P/S 2.093
EFFICIENCY OPERATIONAL
 Operating Leverage 115.385
ASSET & SALES
 Asset Turnover Ratio 0.13
Asset Turnover Ratio QoQ -4.827 %
Asset Turnover Ratio YoY -15.541 %
Asset Turnover Ratio IPRWA high: 0.184
BRKR: 0.13
mean: 0.118
median: 0.108
low: 0.038
 Receivables Turnover 1.504
Receivables Turnover Ratio QoQ 3.526 %
Receivables Turnover Ratio YoY -7.719 %
Receivables Turnover Ratio IPRWA high: 2.963
BRKR: 1.504
mean: 1.343
median: 1.273
low: 0.962
 Inventory Turnover 0.376
Inventory Turnover Ratio QoQ 0.237 %
Inventory Turnover Ratio YoY 1.172 %
Inventory Turnover Ratio IPRWA high: 2.37
median: 1.196
mean: 1.043
BRKR: 0.376
low: 0.187
 Days Sales Outstanding (DSO) 60.673
CASH CYCLE
 Cash Conversion Cycle Days (CCC) 266.13
Cash Conversion Cycle Days QoQ 19.43 %
Cash Conversion Cycle Days YoY -5.195 %
Cash Conversion Cycle Days IPRWA high: 303.302
BRKR: 266.13
mean: 129.589
median: 107.055
low: 51.486
CAPITAL DEPLOYMENT
 Cash Conversion Ratio 0.978
 CapEx To Revenue -0.027
 CapEx To Depreciation -0.38
 
CAPITAL, LIQUIDITY & COVERAGE CAPITAL STRUCTURE
 Total Capital 4.2 B
 Net Invested Capital 4.2 B
 Invested Capital 4.2 B
 Net Tangible Assets -814.80 M
 Net Working Capital 815.3 M
LIQUIDITY
 Cash Ratio 0.068
 Current Ratio 1.605
Current Ratio QoQ 2.234 %
Current Ratio YoY -2.748 %
Current Ratio IPRWA high: 12.395
mean: 2.253
median: 1.933
BRKR: 1.605
low: 0.756
 Quick Ratio 0.701
Quick Ratio QoQ -5.261 %
Quick Ratio YoY -6.423 %
Quick Ratio IPRWA high: 7.325
mean: 1.746
median: 1.496
low: 0.955
BRKR: 0.701
COVERAGE & LEVERAGE
 Debt To EBITDA 33.683
 Cost Of Debt 0.545 %
 Interest Coverage Ratio 1.032
Interest Coverage Ratio QoQ -64.615 %
Interest Coverage Ratio YoY -59.091 %
Interest Coverage Ratio IPRWA high: 33.857
mean: 7.334
median: 5.23
BRKR: 1.032
low: -23.105
 Operating Cash Flow Ratio -0.018
TIMING / LIQUIDITY
 Days Payables Outstanding (DPO) 54.234
DIVIDENDS
 Dividend Coverage Ratio 1.0
 Dividend Payout Ratio 1.0
 Dividend Rate 0.05
 Dividend Yield 0.001
PERFORMANCE GROWTH
 Asset Growth Rate 6.855 %
 Revenue Growth -0.499 %
Revenue Growth QoQ -97.257 %
Revenue Growth YoY -104.559 %
Revenue Growth IPRWA high: 27.38 %
mean: 5.102 %
median: 4.728 %
BRKR: -0.499 %
low: -0.773 %
 Earnings Growth -54.545 %
Earnings Growth QoQ 42.945 %
Earnings Growth YoY 2790.567 %
Earnings Growth IPRWA high: 71.304 %
mean: 7.283 %
median: 4.078 %
BRKR: -54.545 %
low: -61.905 %
MARGINS
 Gross Margin 44.883 %
Gross Margin QoQ -8.055 %
Gross Margin YoY -6.558 %
Gross Margin IPRWA high: 89.231 %
mean: 46.546 %
BRKR: 44.883 %
median: 40.612 %
low: 3.787 %
 EBIT Margin 2.032 %
EBIT Margin QoQ -57.374 %
EBIT Margin YoY -58.916 %
EBIT Margin IPRWA high: 65.47 %
median: 19.467 %
mean: 19.349 %
BRKR: 2.032 %
low: -167.282 %
 Return On Sales (ROS) 3.298 %
Return On Sales QoQ -30.816 %
Return On Sales YoY -33.32 %
Return On Sales IPRWA high: 40.537 %
median: 17.652 %
mean: 17.125 %
BRKR: 3.298 %
low: -167.282 %
CASH FLOW
 Free Cash Flow (FCF) -148.80 M
 Free Cash Flow Yield -2.637 %
Free Cash Flow Yield QoQ -552.316 %
Free Cash Flow Yield YoY 1051.528 %
Free Cash Flow Yield IPRWA high: 13.177 %
mean: 0.655 %
median: 0.637 %
BRKR: -2.637 %
low: -16.613 %
 Free Cash Growth -481.538 %
Free Cash Growth QoQ 545.84 %
Free Cash Growth YoY -91.941 %
Free Cash Growth IPRWA high: 98.619 %
mean: -28.316 %
median: -50.305 %
low: -92.068 %
BRKR: -481.538 %
 Free Cash To Net Income -19.579
 Cash Flow Margin -3.072 %
 Cash Flow To Earnings -3.224
VALUE & RETURNS
 Economic Value Added 0.03
 Return On Assets (ROA) 0.124 %
Return On Assets QoQ -58.108 %
Return On Assets YoY -15.068 %
Return On Assets IPRWA high: 3.831 %
mean: 1.752 %
median: 1.615 %
BRKR: 0.124 %
low: -14.729 %
 Return On Capital Employed (ROCE) 0.324 %
 Return On Equity (ROE) 0.004
Return On Equity QoQ -56.054 %
Return On Equity YoY -0.941 %
Return On Equity IPRWA high: 0.104
mean: 0.036
median: 0.032
BRKR: 0.004
low: -0.217
 DuPont ROE 0.42 %
 Return On Invested Capital (ROIC) 0.302 %
Return On Invested Capital QoQ -52.441 %
Return On Invested Capital YoY -101.383 %
Return On Invested Capital IPRWA high: 5.983 %
mean: 2.46 %
median: 2.332 %
BRKR: 0.302 %
low: -17.594 %

Six-Week Outlook

Technical setup favors tactical upside: MACD’s bullish cross, rising RSI, and price above short-term averages indicate continued short-term momentum that can extend while ADX signals a strong trend environment. MRO’s positive reading and depressed volume caution that upside may encounter mean reversion pressure without increased participation. Structural fundamentals—negative free cash flow, substantial net debt and stretched cash conversion cycle—limit durable rerating and support a view that moves above the 200‑day average ($41.41) will likely require renewed volume and clearer fundamental improvement.

Key technical reference levels: short-term support clusters near the 50‑day average ($33.53) and the super trend lower ($33.94); near-term resistance aligns with the 200‑day average ($41.41). Analyst price targets range broadly (mean $34.50; low $20.28; high $62.97), reflecting dispersion in expectations that complements the present divergence between price action and WMDST valuation.

About Bruker Corporation

Bruker Corporation (NASDAQ:BRKR) designs and develops scientific instrumentation and analytical solutions to advance research and diagnostics across various fields. Headquartered in Billerica, Massachusetts, Bruker operates through four primary segments: BSI BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company provides cutting-edge life science tools and mass spectrometry solutions tailored for the life sciences sector. Bruker’s product offerings include the MALDI Biotyper platform, which enables rapid pathogen identification, and advanced molecular diagnostics kits. The company excels in delivering research and analytical instruments with a focus on process analysis and COVID-19 diagnostic solutions. Additionally, Bruker offers portable analytical systems, X-ray instruments, and electron microscope tools known for their precision and reliability. In the field of nanotechnology, Bruker provides atomic force microscopy and non-contact nanometer resolution solutions. The company also contributes to advancements in superconducting materials and high-tech tools for synchrotron and beamline instrumentation. Since its founding in 1991, Bruker has supported researchers and scientists globally, facilitating groundbreaking discoveries and scientific advancements.



© 2025 WMDST — The World’s Most Dangerous Swing Trader. All rights reserved.